AUG 12, 2026 · PHASE 2 TRIAL
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
ClinicalTrials.gov
This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.
Reported
Sample size5
PhasePhase 2
Primary endpointProgression Free Survival from start of tre…